DUBLIN–(BUSINESS WIRE)–The “Global Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Region: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.
The global biodefense market will reach $15.85 billion by 2030, growing by 6.2% annually over 2020-2030 owing to the rising need for military and civilian vaccines and equipment against diseases including COVID-19 pandemic.
Highlighted with 84 tables and 73 figures, this 165-page report is based on a comprehensive research of the entire global biodefense market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Five Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global biodefense market in every aspect of the classification from perspectives of Product, Sales Channel, Application, and Region.
- Achaogen, Inc.
- Alexeter Technologies LLC
- Alnylam Pharmaceuticals, Inc.
- Altimmune, Inc.
- Bavarian Nordic AS
- BioFactura, Inc.
- Cleveland Biolabs, Inc.
- Dynavax Technologies Inc
- Dynport Vaccine Company LLC (DVC)
- Elusys Therapeutics, Inc.
- Emergent BioSolutions Inc
- General Dynamics Corp.
- GlaxoSmithKline Plc
- Ichor Medical Systems
- Mediimmune (AstraZeneca)
- Nanotherapeutics, Inc.
- Ology Bioscience
- PathSensors Inc
- Pluristem Therapeutics
- Sanofi Pasteur Ltd.
- SIGA Technologies, Inc.
- Soligenix, Inc.
- Xoma Corporation
Key Topics Covered:
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis
3 Segmentation of Global Market by Product
3.1 Market Overview by Product
3.2.7 Other Vaccines
3.3 Biothreat Detection Devices
3.6 Other Products
4 Segmentation of Global Market by Sales Channel
4.1 Market Overview by Sales Channel
4.2 Online Sales
4.3 Offline Sales
5 Segmentation of Global Market by Application
5.1 Market Overview by Application
6 Segmentation of Global Market by Region
6.1 Geographic Market Overview 2019-2030
6.2 North America Market 2019-2030 by Country
6.2.1 Overview of North America Market
6.3 European Market 2019-2030 by Country
6.3.1 Overview of European Market
6.3.8 Rest of European Market
6.4 Asia-Pacific Market 2019-2030 by Country
6.4.1 Overview of Asia-Pacific Market
6.4.6 South Korea
6.4.7 Rest of APAC Region
6.5 South America Market 2019-2030 by Country
6.5.4 Rest of South America Market
6.6 Rest of World Market 2019-2030 by Country
6.6.2 Saudi Arabia
6.6.3 South Africa
6.6.4 Other National Markets
7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
8 Investing in Global Market: Risk Assessment and Management
8.1 Risk Evaluation of Global Market
8.2 Critical Success Factors (CSFs)
For more information about this report visit https://www.researchandmarkets.com/r/lie4dg